GANXGain Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Gain Therapeutics, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GANXThis | $73M#3 | — | 5.2x#9 | 1314.1x#7 | -58.4%#6 | 1.2%#6 | -33908.5%#7 | -143.9%#9 | — | — | 18.5%#2 | — |
| RLYB | $85M#1 | — | 1.7x#6 | 98.6x#4 | 34.9%#3 | 84.5%#3 | -3853.6%#5 | -17.9%#4 | — | — | — | — |
| EMMA | $84M#2 | — | — | 6.8x#3 | -25.2%#5 | -16.1%#8 | 1.9%#3 | — | — | 2#1 | — | — |
| IBIO | $70M#4 | — | 0.9x#3 | 175.7x#6 | 77.8%#2 | 26.2%#4 | -4650.5%#6 | -23.7%#5 | — | — | 117.5%#1 | — |
| SPRO | $68M#7 | 4.3x#1 | 1.3x#4 | 5.4x#2 | 3292.5%#1 | 112.5%#1 | 50.2%#1 | 16.2%#3 | — | — | — | — |
| XBIT | $69M#5 | — | 0.5x#2 | — | -100.0%#7 | -18.2%#10 | — | -33.7%#6 | — | — | — | — |
| TLPH | $68M#6 | — | 3.7x#8 | 2428.2x#8 | — | -9.9%#7 | -48157.1%#8 | -77.3%#8 | — | — | — | — |
| MNOV | $65M#8 | — | 1.7x#5 | 159.2x#5 | — | 8.6%#5 | -3242.5%#4 | 30.4%#2 | — | — | -0.4%#3 | — |
| PLRX | $64M#9 | — | 0.4x#1 | — | — | -29.0%#11 | — | 90.4%#1 | — | — | — | — |
| EVFM | $63M#10 | — | — | 3.1x#1 | 4.2%#4 | 104.4%#2 | 16.7%#2 | — | — | — | — | — |
| CTOR | $61M#11 | — | 1.7x#7 | — | — | -17.1%#9 | — | -70.2%#7 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-08-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice